SCHEMBL14103882

SCHEMBL14103882

Fc1ccc(Oc2nc(-c3ccc(F)c(F)c3)nc3ccsc23)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 3/20 0.43
▸ CYP3A4 P08684 3/20 0.43
▸ CYP2C9 P11712 3/20 0.43
▸ CYP2C19 P33261 3/20 0.43
▸ HTT P42858 2/20 0.43
▸ GAA P10253 2/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.43
▸ MAPT P10636 5/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ LMNA P02545 2/20 0.36
▸ ALDH1A1 P00352 3/20 0.34
▸ HPGD P15428 3/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ ABCG2 Q9UNQ0 1/20 0.34
▸ HRH4 Q9H3N8 1/20 0.34
▸ SCN9A Q15858 2/20 0.34
▸ FPR2 P25090 1/20 0.34
▸ MET P08581 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14104075 0.90 CYP1A2 (0.40) CYP1A2CYP3A4CYP2C9CYP2C19HTT
SCHEMBL14104172 0.86 ABCG2 (0.49) CYP1A2CYP3A4CYP2C9CYP2C19HTT
SCHEMBL14103756 0.86 TRPA1 (0.41) HTTMAPTL3MBTL1METTRPA1
SCHEMBL9881243 0.84 MAPT (0.52) CYP1A2CYP3A4CYP2C9CYP2C19HTT
SCHEMBL14103883 0.82 MAPT (0.44) CYP1A2CYP3A4CYP2C9CYP2C19HTT
SCHEMBL4740942 0.81 PTGS1 (0.46) CYP1A2CYP3A4CYP2C9CYP2C19HTT
SCHEMBL4740291 0.81 PTGS1 (0.46) CYP1A2CYP3A4CYP2C9CYP2C19HTT
SCHEMBL14104446 0.79 TRPA1 (0.41) HTTMAPTL3MBTL1ALDH1A1KDM4E
SCHEMBL14103794 0.78 MAPK1 (0.40) MAPTLMNAALDH1A1HPGDKMT2A
SCHEMBL14103797 0.77 HTT (0.47) CYP1A2CYP3A4CYP2C9CYP2C19HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008092861-A1 BICYCLIC DERIVATIVES AS EP4 AGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2008-08-07 — — WO disclosed
Send feedback